US Stock MarketDetailed Quotes

Neumora Therapeutics (NMRA)

Watchlist
  • 2.130
  • -0.020-0.93%
Close Jan 15 16:00 ET
361.97MMarket Cap-1.45P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neumora Therapeutics (NMRA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-24.72%57.7M
-15.33%54.04M
18.08%70.94M
4.51%263.46M
-44.81%62.92M
34.79%76.65M
51.73%63.82M
53.38%60.07M
85.54%252.1M
271.13%114M
Selling and administrative expenses
-23.95%12.18M
0.80%15.32M
31.21%18.79M
37.52%62.54M
51.39%17.01M
4.93%16.02M
63.50%15.19M
47.86%14.32M
46.12%45.48M
56.16%11.24M
-General and administrative expense
-23.95%12.18M
0.80%15.32M
31.21%18.79M
37.52%62.54M
51.39%17.01M
4.93%16.02M
63.50%15.19M
47.86%14.32M
46.12%45.48M
56.16%11.24M
Research and development costs
-24.92%45.52M
-20.37%38.72M
13.97%52.15M
-2.76%200.93M
-55.32%45.91M
45.74%60.63M
48.40%48.63M
55.19%45.76M
97.26%206.62M
336.88%102.77M
Operating profit
24.72%-57.7M
15.33%-54.04M
-18.08%-70.94M
-4.51%-263.46M
44.81%-62.92M
-34.79%-76.65M
-51.73%-63.82M
-53.38%-60.07M
-85.54%-252.1M
-271.13%-114M
Net non-operating interest income expense
-77.71%938K
-65.59%1.81M
-51.70%3.07M
20.00%19.93M
-27.59%4.09M
9.67%4.21M
48.15%5.27M
78.34%6.37M
264.20%16.61M
147.09%5.65M
Non-operating interest income
-59.97%1.69M
-65.59%1.81M
-51.70%3.07M
20.00%19.93M
-27.59%4.09M
9.67%4.21M
48.15%5.27M
78.34%6.37M
264.20%16.61M
147.09%5.65M
Non-operating interest expense
--747K
----
----
----
----
--0
----
----
----
----
Other net income (expense)
112.28%7K
-1,900.00%-480K
-108.33%-25K
54.12%-78K
114.42%15K
-5,600.00%-57K
38.46%-24K
53.85%-12K
-141.98%-170K
-136.24%-104K
Other non- operating income (expenses)
112.28%7K
-1,900.00%-480K
-108.33%-25K
54.12%-78K
114.42%15K
-5,600.00%-57K
38.46%-24K
53.85%-12K
-141.98%-170K
-136.24%-104K
Income before tax
21.71%-56.76M
10.02%-52.71M
-26.37%-67.89M
-3.37%-243.61M
45.77%-58.82M
-36.71%-72.49M
-51.97%-58.58M
-50.80%-53.72M
-80.02%-235.66M
-285.35%-108.46M
Income tax
0
-80.00%25K
105K
-33.58%178K
0
53K
125K
0
268K
268K
Net income
21.77%-56.76M
10.17%-52.73M
-26.57%-67.99M
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
Net income continuous Operations
21.77%-56.76M
10.17%-52.73M
-26.57%-67.99M
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
Minority interest income
Net income attributable to the parent company
21.77%-56.76M
10.17%-52.73M
-26.57%-67.99M
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
21.77%-56.76M
10.17%-52.73M
-26.57%-67.99M
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
Basic earnings per share
22.22%-0.35
10.81%-0.33
-23.53%-0.42
57.85%-1.53
45.95%-0.37
60.53%-0.45
-45.87%-0.37
-45.02%-0.34
-321.36%-3.63
-269.57%-0.6846
Diluted earnings per share
22.22%-0.35
10.81%-0.33
-23.53%-0.42
57.85%-1.53
45.95%-0.37
60.53%-0.45
-45.87%-0.37
-45.02%-0.34
-321.36%-3.63
-269.57%-0.6846
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -24.72%57.7M-15.33%54.04M18.08%70.94M4.51%263.46M-44.81%62.92M34.79%76.65M51.73%63.82M53.38%60.07M85.54%252.1M271.13%114M
Selling and administrative expenses -23.95%12.18M0.80%15.32M31.21%18.79M37.52%62.54M51.39%17.01M4.93%16.02M63.50%15.19M47.86%14.32M46.12%45.48M56.16%11.24M
-General and administrative expense -23.95%12.18M0.80%15.32M31.21%18.79M37.52%62.54M51.39%17.01M4.93%16.02M63.50%15.19M47.86%14.32M46.12%45.48M56.16%11.24M
Research and development costs -24.92%45.52M-20.37%38.72M13.97%52.15M-2.76%200.93M-55.32%45.91M45.74%60.63M48.40%48.63M55.19%45.76M97.26%206.62M336.88%102.77M
Operating profit 24.72%-57.7M15.33%-54.04M-18.08%-70.94M-4.51%-263.46M44.81%-62.92M-34.79%-76.65M-51.73%-63.82M-53.38%-60.07M-85.54%-252.1M-271.13%-114M
Net non-operating interest income expense -77.71%938K-65.59%1.81M-51.70%3.07M20.00%19.93M-27.59%4.09M9.67%4.21M48.15%5.27M78.34%6.37M264.20%16.61M147.09%5.65M
Non-operating interest income -59.97%1.69M-65.59%1.81M-51.70%3.07M20.00%19.93M-27.59%4.09M9.67%4.21M48.15%5.27M78.34%6.37M264.20%16.61M147.09%5.65M
Non-operating interest expense --747K------------------0----------------
Other net income (expense) 112.28%7K-1,900.00%-480K-108.33%-25K54.12%-78K114.42%15K-5,600.00%-57K38.46%-24K53.85%-12K-141.98%-170K-136.24%-104K
Other non- operating income (expenses) 112.28%7K-1,900.00%-480K-108.33%-25K54.12%-78K114.42%15K-5,600.00%-57K38.46%-24K53.85%-12K-141.98%-170K-136.24%-104K
Income before tax 21.71%-56.76M10.02%-52.71M-26.37%-67.89M-3.37%-243.61M45.77%-58.82M-36.71%-72.49M-51.97%-58.58M-50.80%-53.72M-80.02%-235.66M-285.35%-108.46M
Income tax 0-80.00%25K105K-33.58%178K053K125K0268K268K
Net income 21.77%-56.76M10.17%-52.73M-26.57%-67.99M-3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M
Net income continuous Operations 21.77%-56.76M10.17%-52.73M-26.57%-67.99M-3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M
Minority interest income
Net income attributable to the parent company 21.77%-56.76M10.17%-52.73M-26.57%-67.99M-3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 21.77%-56.76M10.17%-52.73M-26.57%-67.99M-3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M
Basic earnings per share 22.22%-0.3510.81%-0.33-23.53%-0.4257.85%-1.5345.95%-0.3760.53%-0.45-45.87%-0.37-45.02%-0.34-321.36%-3.63-269.57%-0.6846
Diluted earnings per share 22.22%-0.3510.81%-0.33-23.53%-0.4257.85%-1.5345.95%-0.3760.53%-0.45-45.87%-0.37-45.02%-0.34-321.36%-3.63-269.57%-0.6846
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -